About Perosphere
Perosphere is a company based in Mount Kisco (United States) founded in 2011 was acquired by AMAG Pharma in January 2019. Perosphere has raised $9.36 million across 4 funding rounds from investors including AMAG Pharma and Connecticut Innovations. The company has 13 employees as of December 31, 2018. Perosphere operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others.
- Headquarter Mount Kisco, United States
- Employees 13 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perosphere Pharmaceuticals Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.36 M (USD)
in 4 rounds
-
Latest Funding Round
$6.21 M (USD), Series A
Feb 04, 2016
-
Investors
AMAG Pharma
& 1 more
-
Employee Count
13
as on Dec 31, 2018
-
Acquired by
AMAG Pharma
(Jan 17, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Perosphere
Perosphere has successfully raised a total of $9.36M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.21 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Perosphere
Perosphere has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include AMAG Pharma and Connecticut Innovations.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
Manufacturer of anemia based products and imaging agents for cancer and CVD diagnosis
|
Locked | Locked | Locked |
Investor details for Perosphere
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Perosphere
Investment portfolio details for Perosphere
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Perosphere
Detailed financials for Perosphere
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perosphere Comparisons
Peer comparison for Perosphere
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Perosphere
Perosphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| Locked | Locked | Locked |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| Locked | Locked | Locked |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| Locked | Locked | Locked |
Handheld devices for blood clot monitoring are provided by Microvisk.
|
Detailed competitors of Perosphere
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perosphere
Complete news archive for Perosphere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Perosphere
Perosphere was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Perosphere is headquartered in Mount Kisco, United States. It is registered at Mount Kisco, New York, United States.
Perosphere is a funded company, having raised a total of $9.36M across 4 funding rounds to date.
As of Dec 31, 2018, the latest employee count at Perosphere is 13.
Perosphere is a specialty pharmaceutical company. Perospheres lead investigational drug product candidate is ciraparantag (PER977). Ciraparnatag is an intravenously administered synthetic molecule designed as a broad-spectrum reversal agent for anticoagulants. In pipeline there is PER1080 to prevent allergic reactions to peanuts and other allergens; PER726 is an intravenous therapeutic drug candidate that seeks to reduce brain cell damage, which typically occurs after cardiac arrest, stroke, or traumatic brain injury. Also, has an investigational device product candidate: point-of-care coagulometer, a hand-held device that tests fresh or citrated whole blood.
Perosphere's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.
Perosphere has 2 investors. Key investors include AMAG Pharma, and Connecticut Innovations.